Leukemia derived dendritic cell (DCleu) mediated immune response goes along with reduced (leukemia-specific) regulatory T-cells-Reference-Cited by-同舟云学术

Leukemia derived dendritic cell (DCleu) mediated immune response goes along with reduced (leukemia-specific) regulatory T-cells

Published:2022-07 Issue:4 Volume:227 Page:152237
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Pepeldjiyska Elena,Li Lin,Gao Jincheng,Seidel Corinna L.,Blasi Christian,Özkaya Erdem,Schmohl Jörg,Kraemer Doris,Schmid Christoph,Rank Andreas,Schmetzer Helga Maria

Funder

China Scholarship Council

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference74 articles.

1. Dendritic cells of leukemic origin: specialized antigen-presenting cells as potential treatment tools for patients with myeloid leukemia;Amberger;Transfus Med. Hemother.,2020

2. PGE(1)-containing protocols generate mature (leukemia-derived) dendritic cells directly from leukemic whole blood;Amberger;Int. J. Mol. Sci.,2019

3. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC(leu));Ansprenger;Clin. Immunol.,2020

4. ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chicken;Ariaans;Dev. Comp. Immunol.,2008

5. Detection of T-cell degranulation: CD107a and b;Betts;Methods Cell Biol.,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition;Frontiers in Bioscience-Landmark;2024-08-20

2. Anti-Leukemic Effects Induced by Dendritic Cells of Leukemic Origin from Leukemic Blood Samples Are Comparable under Hypoxic vs. Normoxic Conditions;Cancers;2024-06-28

3. Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients’ Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays;International Journal of Molecular Sciences;2024-06-26

4. Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective;Biomedicine & Pharmacotherapy;2024-02

5. Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients’ Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture;International Journal of Molecular Sciences;2023-12-13